Skip to content
healthcare.dev

TADALAFIL

NDC 68788-8664, tadalafil, tablet, from Preferred Pharmaceuticals Inc..

Product NDC
68788-8664
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210609
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL20 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
68788-8664-16878886640115 TABLET in 1 BOTTLE (68788-8664-1)
68788-8664-36878886640330 TABLET in 1 BOTTLE (68788-8664-3)
68788-8664-7687888664077 TABLET in 1 BOTTLE (68788-8664-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/09ad27a1-3908-4533-b84c-7a7fd3514101

Use it

Look up 68788-8664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-8664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.